Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA) [Phase 1]
This Phase 1 trial evaluates the safety of FURESTEM-RA injections in patients with moderate to severe rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis. [Phase 2, Phase 3]
A completed Phase 2/Phase 3 safety analysis evaluating oral prednisone as a pre-treatment for rituximab in rheumatoid arthritis, reporting s…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With Tocilizumab (RoActemra/Actemra)
A completed non-interventional study of rheumatoid arthritis patients treated with tocilizumab (RoActemra/Actemra) with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Work Interventions to Improve Employment Outcomes for Persons With Rheumatoid Arthritis and Osteoarthritis [NA]
A completed clinical trial evaluating work interventions to improve employment outcomes for people with rheumatoid arthritis and osteoarthri…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: RAHelp.Org: An Online Self Management Program for Adults With Rheumatoid Arthritis [NA]
This document reports a completed clinical trial evaluating RAHelp.Org, an online self-management program for adults with rheumatoid arthrit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-09-30Clinical Trial Update: Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis [Phase 1]
This update announces the completion of a Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of AMP-110 in subjects wit…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis [Phase 2]
This document reports results from a Phase 2 study of mavrilimumab in adults with moderate-to-severe rheumatoid arthritis. The trial status …
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Norspan (fentanyl transdermal patch) for moderate-to-severe pain due to osteoar…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis [Phase 3]
A long-term safety extension study of WA19926 in rheumatoid arthritis completed Phase 3, with safety results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis [Phase 3]
Open-label Phase 3 trial evaluating tocilizumab (RoActemra/Actemra) in adults with moderate to severe rheumatoid arthritis; results were pos…
-
CLINICAL_TRIALS withdrawal · 2016-09-20Clinical Trial Update: Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis [Phase 2]
Open-label extension safety study of PROCRIT (epoetin alfa) in anemia of chronic disease due to rheumatoid arthritis has been withdrawn.
-
FDA approval · 2016-09-16FDA Approved: CELECOXIB — Supplemental Application (Apotex Corp.)
The FDA approved Apotex Corp.'s supplemental application for celecoxib (generic) under ANDA204197.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis [Phase 1, Phase 2]
This Phase I/II multi-dose rheumatoid arthritis trial compared LEA29Y with CTLA-4Ig and placebo and has completed.
-
CLINICAL_TRIALS research · 2016-09-16Clinical Trial Update: Predictors of Adherence to Orencia
This clinical trial update reports on factors predicting adherence to abatacept (Orencia) in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates [Phase 1]
A Phase 1 study completed to evaluate the effect of BMS-986142 on the pharmacokinetics of probe substrates in subjects with Rheumatoid Arthr…
-
CLINICAL_TRIALS research · 2016-09-15Clinical Trial Update: An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
An observational study of tocilizumab (RoActemra/Actemra) in patients with rheumatoid arthritis, sponsored by Hoffmann-La Roche, has been te…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory Arthritis [NA]
This clinical trial update reports validation of a self-administered questionnaire for assessing calcium intake in patients with Multiple Sc…
-
FDA approval · 2016-09-14FDA Approved: CELECOXIB — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for CELECOXIB from Aurobindo Pharma Limited (ANDA206827). This notice confirms the supplemental appr…
-
FDA label_change · 2016-09-13FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.)
FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.) indicating a labeling modification related to celecoxib.
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate [Phase 3]
This is a Phase 3 clinical trial evaluating abatacept in Chinese patients with active rheumatoid arthritis who had an inadequate response to…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Study of the Influence of the Expression of the Calcium-sensitive Receptor (CaSR) by Monocytes in the Synovial Liquid on Structural Alterations in Patients Diagnosed With Rheumatoid Arthritis in the Previous Two Years
This completed clinical trial investigated whether calcium-sensing receptor expression by monocytes in synovial fluid correlates with struct…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects [Phase 1]
A Phase 1 study evaluating the impact of a high-fat meal on the pharmacokinetics of SHR0302 and performing a mass balance study in healthy s…
-
CLINICAL_TRIALS research · 2016-09-07Clinical Trial Update: Low Dose Dexamethasone in Supraclavicular Blocks [NA]
This document provides an update on a clinical trial evaluating low-dose dexamethasone used in supraclavicular nerve blocks; the current tri…
-
FDA approval · 2016-09-02FDA Approved: DICLOFENAC SODIUM — Original Application (SOLA Pharmaceuticals, LLC)
FDA approved SOLA Pharmaceuticals' diclofenac sodium tablet as an original generic, indicated for relief of pain and inflammation in conditi…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: Effectiveness and Safety of Physical Exercises in the Improvement of the Sleep Quality. Regarding Rheumatoid Arthritis [NA]
A completed clinical trial evaluated whether physical exercise improves sleep quality and assessed safety in people with rheumatoid arthriti…